Subcutaneous injection of midazolam attenuates hyperglycemia-induced microvascular leakage and cancer metastasis by inhibiting TGase2-mediated VE-cadherin disassembly in the lungs of type 1 diabetic mice 89. Here, TGM2 is linked to Hyperglycemia.